Neuropathic Pain

Higmark Interactive will now be able to market their full suite of EQ software modules.

What a longtime family practitioner in a state that authorizes medical aid in dying has learned through his own experience of the controversial practice.

The SPRINT endura and extensa are cleared for both chronic and acute pain including post-operative pain and post-traumatic pain.

The celebrity chef-turned-producer wants to champion healthcare access, both on the screen and in person. Where does he start?

If approved, the therapeutic will be the first in a new class of medicines.

Already tasked with a burdensome regimen of therapy for nerve damage, some patients may just be looking for simpler relief.

Results from a study published in the Orphanet Journal of Rare Diseases this week suggest that the hereditary neuropathy with liability to pressure palsies, which has been assumed to be rare, might not be uncommon in the Korean population.

The ZTlido patch utilizes a 36-mg dose of lidocaine, compared to the 700-mg dose used by other available patches.

For close to two decades researchers have been working to develop vaccines to prevent people from health hazards like smoking and drug use. Despite these efforts work remains to find ways to make these effective for a large number of people at risk.

Different types of pain respond to different medications; so a collaborative team across the United States and United Kingdom looked at how the Chronic Pain Questionnaire (CPQ) can assist in making those important treatment decisions.

There have been big steps taken to help combat the opioid abuse epidemic but there is still much more work to be done. Several leading organizations and pharmaceutical companies to help patients with overdose and prevent abuse in the first place.

For patients who do not need opioids or other strong medications for pain management there are other steps that can be taken to help them better manage their symptoms and issues.

One of the biggest concerns in the opioid epidemic is the medications being abused by patients and those who get the drugs through other methods. While technology is being developed to help in this issue getting these changes into the market has been more difficult so far.

The opioid epidemic is clearly a growing problem in the medical community. However, there are concerns that there is so much concern about prescribing opioids that they are not being given who can benefit most from them.

Presented at PAINWeek 2016 in Las Vegas, Nevada, researchers looked at how turmeric could be used as a safer, more tolerable option for pain control.

In March 2016, the Centers for Disease Control and Prevention (CDC) published new guidelines for prescribing opioids. And while the aim is to curb the deadly opioid epidemic, some physicians saying that the changes could cause other prescription issues.

Oxycodone, morphine, hydrocodone, and codeine are among the commonly recognized prescription painkillers. But levorphanol is one that has been around since 1953, yet is often left behind for a newer medication.

A recent study published in The Journal of Pain looked at the effect of marijuana treatment on neuropathic pain.

While it is clear the opioid abuse problem is not going away, those working in the field are still determined to ensure that the problems of the past do not interfere with success in the future.

As the field of pain medicine advances there is a considerable focus on helping patients get better as well as undoing the damage done by the opioid abuse epidemic. Both problems will likely require a long term approach to be successful.

For some patients, especially on a short term basis opioids may still be the best treatment option. Safely prescribing these medications is the focus of a field looking to help patients without causing problems in other areas.

As it is becoming clearer how dangerous opioids can be for some patients work is being done to find alternatives to help manage pain without as much fear of addiction.

Researchers caution that Pregabalin, an agent approved by the FDA to treat epilepsy, fibromyalgia, and neuropathic pain, may be associated with an increased risk of major birth defects after first trimester exposure, though results are inconclusive.

With doctors having busy schedules to begin with it can be difficult to help patients who may have an addiction or issue with opioids. Taking a few extra minutes can sometimes make all the difference in helping these vulnerable patients avoid a much worse scenario.

While looking to find ways to treat patients with pain beyond opioids a considerable amount of research has been done looking at alternative medications and treatments that can provide relief without the potential risks of addiction.

In the struggle against the growing opioid epidemic the CDC recently announced new guidelines aimed at helping guide doctors on when to prescribe this form of medication and what other steps can be done to help patients.

Neurologic abnormalities are apparent just days after human immunodeficiency virus (HIV) infection, according to a new study published in Neurology.

Pain medications can often cause side effects such as dizziness and sleepiness; but little do pregnant women know that they could be at risk for birth defects when taking pregabalin.

French researchers examined several factors that could contribute to an association between antiepileptic drug use and risk of suicide attempt.

Researchers reported that reawakened astrocytes appear to be a key trigger for S1 cortex (the remote region of the brain that is not directly affected by spinal cord injury) circuit rewiring and may contribute to sustained neuropathic mechanical allodynia.